Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, přehledy
PubMed
30116971
DOI
10.1007/s11102-018-0907-1
PII: 10.1007/s11102-018-0907-1
Knihovny.cz E-zdroje
- Klíčová slova
- Cerebrospinal fluid leak, Dopamine agonists, Prolactinoma, Rhinorrhea,
- MeSH
- agonisté dopaminu škodlivé účinky terapeutické užití MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- prolaktin metabolismus MeSH
- prolaktinom farmakoterapie MeSH
- retrospektivní studie MeSH
- rinorea mozkomíšního moku chemicky indukované MeSH
- senioři MeSH
- únik mozkomíšního moku chemicky indukované MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- agonisté dopaminu MeSH
- prolaktin MeSH
PURPOSE: Although several reports have addressed cerebrospinal fluid (CSF) rhinorrhea following dopamine agonist (DA) therapy of macroprolactinomas, further study is warranted for this relatively uncommon entity. Toward this aim, our retrospective series and review of literature further clarifies recommendations in treatment of this rare problem. METHODS: We retrospectively reviewed all macroprolactinoma cases in our hospital for a 15-year period. Our systematic search of PubMed identified original articles and reviews of all macroprolactinoma cases with an associated medication-induced CSF leak. RESULTS: Five patients with drug-induced CSF leak were identified; four of these patients received cabergoline therapy an average of 6 weeks before the onset of rhinorrhea and then underwent surgical repair of the CSF leak. Of 35 published studies included, we identified 60 patients with medication-induced CSF leak. Medical therapy included bromocriptine in 34 patients, cabergoline in 21 patients, and use of both DAs in two patients. Three cases did include complete diagnostic and treatment data. Median time from initiation of the DA treatment to occurrence of rhinorrhea was 6 weeks. For CSF rhinorrhea, 49 patients underwent surgical repair (38 by the transnasal approach) and seven patients were treated nonoperatively. CONCLUSION: Baseline skull base erosion in macroprolactinomas in combination with subsequent tumor shrinkage induced by DA therapy may result in spontaneous CSF rhinorrhea. Therefore, such patients should be advised about and monitored for this potential setback. Once CSF leak is diagnosed, prompt treatment must be carried out to avoid infectious complications. Transnasal surgery appears the most effective therapeutic approach.
Zobrazit více v PubMed
J Clin Neurosci. 2015 Oct;22(10):1568-74 PubMed
Cell. 1991 Jul 12;66(1):107-19 PubMed
Int Forum Allergy Rhinol. 2016 Jan;6(1):8-16 PubMed
Am J Med. 1987 Nov;83(5):995-1002 PubMed
Clin Diabetes Endocrinol. 2015 Jul 20;1:5 PubMed
J Clin Endocrinol Metab. 1997 Nov;82(11):3574-9 PubMed
Otolaryngol Head Neck Surg. 2004 Apr;130(4):443-8 PubMed
Laryngoscope. 2006 Oct;116(10):1882-6 PubMed
J Clin Endocrinol Metab. 2000 Aug;85(8):2931-5 PubMed
Clin Endocrinol (Oxf). 1994 Sep;41(3):359-64 PubMed
Acta Neurochir (Wien). 1989;96(3-4):107-13 PubMed
Cell. 2005 Feb 11;120(3):303-13 PubMed
Laryngoscope. 2005 Feb;115(2):205-12 PubMed
J Clin Endocrinol Metab. 2010 Apr;95(4):1708-16 PubMed
No Shinkei Geka. 1992 Oct;20(10):1091-5 PubMed
Endocr Rev. 1992 May;13(2):220-40 PubMed
Laryngoscope. 2004 Jun;114(6):969-74 PubMed
Eur J Endocrinol. 2008 Jan;158(1):11-8 PubMed
J Clin Endocrinol Metab. 2012 Oct;97(10):3412-3 PubMed
N Engl J Med. 1994 Oct 6;331(14):904-9 PubMed
Surg Neurol. 1982 Jul;18(1):61-3 PubMed
Int Forum Allergy Rhinol. 2012 Sep-Oct;2(5):397-401 PubMed
J Clin Neurosci. 2015 Oct;22(10):1562-7 PubMed
Endocr Pract. 2010 Jan-Feb;16(1):42-6 PubMed
Pituitary. 2004;7(2):83-7 PubMed
Clin Endocrinol (Oxf). 2009 Apr;70(4):588-92 PubMed
Ann Saudi Med. 1994 Jan;14(1):64-7 PubMed
Pituitary. 2005;8(2):147-54 PubMed
Laryngoscope Investig Otolaryngol. 2017 Apr 07;2(5):215-224 PubMed
Am J Rhinol Allergy. 2016 Nov 1;30(6):424-429 PubMed
Medicine (Baltimore). 2017 Jan;96(2):e5833 PubMed
Neurosurgery. 1982 Sep;11(3):395-401 PubMed
AMA Arch Otolaryngol. 1952 Jul;56(1):1-12 PubMed
Minim Invasive Neurosurg. 1998 Jun;41(2):66-73 PubMed
Melanoma Res. 2005 Oct;15(5):417-25 PubMed
J Endocrinol Invest. 2001 Mar;24(3):183-7 PubMed
Clin Endocrinol (Oxf). 2000 Jan;52(1):43-9 PubMed
Clin Endocrinol (Oxf). 2000 Oct;53(4):529-34 PubMed
Surg Neurol. 1989 Nov;32(5):346-9 PubMed
Surg Neurol. 2009 Nov;72(5):461-3; discussion 463 PubMed
J Clin Endocrinol Metab. 1992 Jul;75(1):275-80 PubMed
N Engl J Med. 2004 Mar 4;350(10):1054-7; author reply 1054-7 PubMed
Pituitary. 2002;5(4):243-6 PubMed
Clin Endocrinol (Oxf). 2013 Oct;79(4):447-56 PubMed
J Neurooncol. 2014 May;117(3):421-8 PubMed
Neurocirugia (Astur). 2011 Dec;22(6):558-61; discussion 561 PubMed
Arq Neuropsiquiatr. 2001 Jun;59(2-A):263-5 PubMed
Ear Nose Throat J. 1992 Jul;71(7):300-5 PubMed
Q J Med. 1990 Mar;74(275):227-38 PubMed
J Clin Endocrinol Metab. 2007 Oct;92(10):3829-35 PubMed
Endocrinol Metab Clin North Am. 2008 Mar;37(1):67-99, viii PubMed
Neurosurgery. 1997 Feb;40(2):225-36; discussion 236-7 PubMed
N Engl J Med. 2003 Nov 20;349(21):2035-41 PubMed
Neurosurg Focus. 2010 Oct;29(4):E4 PubMed
Clin Endocrinol (Oxf). 2000 Jul;53(1):53-60 PubMed
Nat Med. 1998 Aug;4(8):909-14 PubMed
Neurosurg Rev. 2007 Jan;30(1):78-82; discussion 82 PubMed
J Clin Invest. 2004 Sep;114(5):623-33 PubMed
Neurology. 1985 Aug;35(8):1193-5 PubMed
Brain Pathol. 2011 Sep;21(5):533-43 PubMed
Surg Neurol. 1992 Oct;38(4):321 PubMed
N Engl J Med. 1979 Jun 14;300(24):1391 PubMed
J Clin Endocrinol Metab. 2015 Apr;100(4):1699-708 PubMed
Eur J Endocrinol. 2007 Oct;157(4):371-82 PubMed
J Neurol Surg A Cent Eur Neurosurg. 2013 Dec;74 Suppl 1:e50-3 PubMed
Acta Clin Belg. 2009 Sep-Oct;64(5):457 PubMed
N Engl J Med. 1982 Jan 21;306(3):178 PubMed
Hum Pathol. 2014 Jan;45(1):71-7 PubMed
Acta Endocrinol (Copenh). 1983 Aug;103(4):457-60 PubMed
J Clin Neurosci. 2004 Nov;11(8):825-8 PubMed
Am J Pathol. 2003 May;162(5):1503-13 PubMed
Pituitary. 2014 Apr;17(2):97-102 PubMed
Cancer Res. 2002 Mar 1;62(5):1326-9 PubMed
J Clin Endocrinol Metab. 2008 Dec;93(12):4721-7 PubMed
AJNR Am J Neuroradiol. 2000 Feb;21(2):337-42 PubMed
Neurosurg Focus. 2012 Jun;32(6):E2 PubMed
J Clin Endocrinol Metab. 1985 Apr;60(4):698-705 PubMed
J Clin Endocrinol Metab. 2011 Feb;96(2):273-88 PubMed
Am J Surg Pathol. 2011 Aug;35(8):1204-13 PubMed
Clin Endocrinol (Oxf). 2003 May;58(5):662-70 PubMed
Surg Neurol. 1994 Jun;41(6):486-9 PubMed
Eur J Endocrinol. 2013 Nov 22;170(1):31-8 PubMed
J Hum Reprod Sci. 2011 May;4(2):104-5 PubMed
Cell. 2006 Jan 27;124(2):263-6 PubMed
Eur J Endocrinol. 2014 Jun;170(6):R213-27 PubMed
Neurosurg Focus. 2012 Jun;32(6):E7 PubMed
Aust N Z J Med. 2000 Jun;30(3):399-400 PubMed
J Neurosurg. 2002 Aug;97(2):299-306 PubMed
Laryngoscope. 2004 Jun;114(6):991-9 PubMed
Ann Endocrinol (Paris). 1994;54(5):347-51 PubMed
J Clin Endocrinol Metab. 1999 Jul;84(7):2518-22 PubMed
Mod Pathol. 2002 Dec;15(12):1357-65 PubMed
Neurology. 1984 Jan;34(1):111-3 PubMed
J Endocrinol Invest. 2006 Dec;29(11):1001-5 PubMed
Clin Endocrinol (Oxf). 1985 May;22(5):573-81 PubMed
Curr Opin Otolaryngol Head Neck Surg. 2015 Feb;23(1):78-82 PubMed